PROSHARES TRUST (ZBIO) Enterprise Value: 2023-2025
Historic Enterprise Value for Zenas BioPharma (ZBIO) over the last 2 years, with Sep 2025 value amounting to $457.9 million.
- Zenas BioPharma's Enterprise Value fell 8.63% to $457.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$827.0 million, marking a year-over-year decrease of 470.75%. This contributed to the annual value of -$8.5 million for FY2024, which is 85.05% up from last year.
- Per Zenas BioPharma's latest filing, its Enterprise Value stood at $457.9 million for Q3 2025, which was up 563.49% from -$98.8 million recorded in Q2 2025.
- In the past 5 years, Zenas BioPharma's Enterprise Value registered a high of $501.2 million during Q3 2024, and its lowest value of -$184.0 million during Q2 2024.
- Its 3-year average for Enterprise Value is $53.2 million, with a median of -$37.2 million in 2024.
- Its Enterprise Value has fluctuated over the past 5 years, first skyrocketed by 793.10% in 2024, then decreased by 8.63% in 2025.
- Quarterly analysis of 3 years shows Zenas BioPharma's Enterprise Value stood at -$56.9 million in 2023, then soared by 85.05% to -$8.5 million in 2024, then declined by 8.63% to $457.9 million in 2025.
- Its last three reported values are $457.9 million in Q3 2025, -$98.8 million for Q2 2025, and -$22.6 million during Q1 2025.